Company / SG&A Expense
AETHLON MEDICAL INC SG&A Expense History
FY2014-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A Expense
$3.2M
FY2024
5-year range
$953.5K / $4.5M
FY2020-FY2024
Trend
-16.9%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
SG&A Expense has fluctuated over the past 10 years, ranging from $746,099 in FY2014 to $4M in FY2022.
Based on SEC 10-K filings.
$3M in FY2024 with a 10-year CAGR of +15.8%.
Improved from $4M to $3M over the past 2 years.
SG&A Expense over time
Growth rates
- 3-Year CAGR
- +27.9%
- 5-Year CAGR
- -
- 10-Year CAGR
- +15.8%
Key checks
Key Insights
- 3-year CAGR of +27.9%, indicating consistent growth.
- In FY2024, sg&a expense decreased 16.9% year-over-year.
- Peak sg&a expense was recorded in FY2022.
- Lowest sg&a expense in the period was in FY2014.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -18.04 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $3.2M | -16.9% |
| FY2023 | $3.9M | -12.9% |
| FY2022 | $4.5M | +189.4% |
| FY2021 | $1.5M | +62.4% |
| FY2020 | $953.5K | +0.0% |
| FY2018 | $953.5K | +2.6% |
| FY2017 | $929.0K | +9.4% |
| FY2016 | $849.5K | -8.8% |
| FY2015 | $931.1K | +24.8% |
| FY2014 | $746.1K | -12.5% |
As of FY2024 · SEC 10-K · Updated Jun 24, 2026